Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
Holding AMRX?
Track your performance easily
Amneal Pharmaceuticals (AMRX) Ownership Overview
25.76% Insiders
8.97% Mutual Funds
12.89% Other Institutional Investors
9.02% ETFs
43.36% Public Companies and
Individual Investors
The ownership structure of Amneal Pharmaceuticals (AMRX) stock is a mix of institutional, retail, and individual investors. Approximately 30.88% of the company’s stock is owned by Institutional Investors, 25.76% is owned by Insiders, and 43.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 26, 2024 | John Kiely Director | xxxxxxxxxxxxx | $142946 |
| Nov 25, 2024 | Deborah M. Autor Director | xxxxxxxxxxxxx | $334074 |
| Nov 22, 2024 | Jason B. Daly Svp, Clo | xxxxxxxxxxxxx | $114786 |
| Nov 19, 2024 | Jason B. Daly Svp, Clo | xxxxxxxxxxxxx | $375887 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $105872 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $242528 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $396522 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1747200 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,856,413 | Insider | 8.80% | 208,942,893 | |
| 25,265,818 | Insider | 8.15% | 196,568,064 | |
| 21,781,986 | Insider | 7.03% | 169,463,851 | |
| 13,903,992 | Institution | 4.49% | 108,173,058 | |
| 12,371,889 | Institution | 3.99% | 96,253,296 | |
| 6,925,804 | Institution | 2.24% | 53,882,755 | |
| 2,075,717 | Institution | 0.67% | 16,149,078 | |
| 2,048,886 | Insider | 0.66% | 15,940,333 | |
| 1,959,627 | Institution | 0.63% | 15,245,898 | |
| 1,791,483 | Institution | 0.58% | 13,937,738 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,371,889 | Institution | 3.99% | 96,253,296 | |
| 1,959,627 | Institution | 0.63% | 15,245,898 | |
| 1,791,483 | Institution | 0.58% | 13,937,738 | |
| 1,473,400 | Institution | 0.48% | 11,463,052 | |
| 1,383,340 | Institution | 0.45% | 10,762,385 | |
| 1,319,570 | Institution | 0.43% | 10,266,255 | |
| 1,056,854 | Institution | 0.34% | 8,222,324 | |
| 903,340 | Institution | 0.29% | 7,027,985 | |
| 799,405 | Institution | 0.26% | 6,219,371 | |
| 597,792 | Institution | 0.19% | 4,650,822 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,364,427 | Institution | 1.41% | 36,966,697 | |
| 4,598,757 | Institution | 1.48% | 35,778,329 | |
| 3,498,775 | Institution | 1.13% | 29,634,624 | |
| 2,360,216 | Institution | 0.76% | 19,991,030 | |
| 2,155,080 | Institution | 0.70% | 18,253,528 | |
| 1,226,978 | Institution | 0.40% | 9,545,889 | |
| 906,658 | Institution | 0.29% | 7,053,799 | |
| 794,484 | Institution | 0.26% | 6,157,251 | |
| 724,726 | Institution | 0.23% | 6,138,429 | |
| 764,177 | Institution | 0.25% | 5,945,297 |
FAQ
Who Owns Amneal Pharmaceuticals Inc (AMRX)?
According to the latest TipRanks data, approximately 12.89% of the company's stock is held by institutional investors, 25.76% is held by insiders, and 43.36% is held by retail investors.
What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.89% of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors.
What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.36% of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors.
Who owns the most shares of Amneal Pharmaceuticals Inc (AMRX)?
Mahesh Akram owns the most shares of Amneal Pharmaceuticals Inc (AMRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.